HopeStage
Study directory

Schizophrenia studies

Schizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.

Back to overview
More filters: keywords, city, remote
4505studies shown
Showing 205-216 of 4,505
Drug study icon
Not Yet RecruitingNCT06474286

Prucalopride for Cognitive Functioning in Schizophrenia

What is this study about?

Researchers are studying Prucalopride 1 MG to find out how it affects psychotic symptoms in people with schizophrenia.

This study isn't recruiting yet.

In Mangalore
SchizophreniaMedication studyAges 18–55
Countries
India
Sponsor
University of Pittsburgh
Biological study icon
Not Yet RecruitingNCT07485751

Safety and Feasibility of Nasal Delivery of Human Dental Follicle Mesenchymal Stem Cell-Derived Exosomes for Negative Symptoms for schizophrenia

Official study title

Safety and Feasibility of Nasal Delivery of Human Dental Follicle Mesenchymal Stem Cell-Derived Exosomes for Negative Symptoms in Treatment-Resistant Schizophrenia: A Pilot Study

This study isn't recruiting yet.

Location not clearly listed
SchizophreniaInterventional studyAges 18–60
Countries
Sponsor
Zigong Mental Health Center
Drug study icon
Not Yet RecruitingNCT05416658

Shared Decision Making for Antipsychotic Medications

Official study title

Examining the Effectiveness of a Shared Decision Making Intervention for Antipsychotic Medications to Improve Engagement in Treatment for People Experiencing Early Psychosis

This study isn't recruiting yet.

Location not clearly listed
SchizophreniaInterventional studyAges 18–30
Countries
Sponsor
New York State Psychiatric Institute
Other study type icon
Not Yet RecruitingNCT07108673

Value of Voxel-Based Morphometry in Schizophrenia

Official study title

Value of Voxel-Based Morphometry in Assessing Brain Structural Abnormalities in Schizophrenia and Nicotine Use Disorder.

This study isn't recruiting yet.

Location not clearly listed
SchizophreniaObservational studyAges 18–60
Countries
Sponsor
Assiut University
Drug study icon
Enrolling By InvitationNCT07521683

NS-136 for schizophrenia

What is this study about?

This study evaluates the safety and effectiveness of NS-136 for people with schizophrenia.

This study is by invitation only.

In Shanghai
SchizophreniaMedication studyAges 18–65
Countries
China
Sponsor
NeuShen Therapeutics
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.